openPR Logo
Press release

Overview of Transplantation Drug Development Pipeline Industry : Size, Share, Trends and Analysis 2017

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Transplantation Drug Development Pipeline Review, 2017" to its huge collection of research reports.

Transplantation Drug Development Pipeline Review, 2017

Summary
This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for graft-versus-host disease (GVHD), and the rejection of bone, liver, kidney, lung and heart transplants.

Transplant rejection is a complication that can occur after the replacement of a defective host organ with a foreign donor organ. General risks associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Additionally, following a transplant, the immune system may consider the transplanted heart as foreign and mount a response against it, especially if the antigens expressed by the tissues in each do not match. Generally, immunosuppressive drugs are administered simultaneously with the transplant in order to minimize this risk. These immunosuppressive drugs prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1217019

The size of these pipelines ranges from seven products in heart transplantation to 121 in bone marrow transplantation. A wide range of targets, including integrins, chemokine receptors, protein kinases and cadherins are being developed, with no particular class of target predominating in terms of pipeline volume within each indication. However, there is a clear trend towards immune system molecular targets being studied, reflecting the underlying immune-based pathophysiology of these indications.

Scope
- Which companies are the most active within the pipeline for transplantation therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of transplantation therapeutics?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Make an Enquiry about TOC @ https://www.researchmoz.us/transplantation-drug-development-pipeline-review-2017-report.html/toc

Table of Contents

GBI Research Report Guidance 2
Executive Summary 3
Table of Contents 4
List of Tables 6
List of Figures 12
Introduction 14
Transplantation Report Coverage 14
Bone Marrow Transplant Rejection - Overview 14
Graft Versus Host Disease (GVHD) - Overview 14
Liver Transplant Rejection - Overview 14
Kidney Transplant Rejection - Overview 14
Lung Transplant Rejection - Overview 14
Heart Transplant Rejection - Overview 15
Therapeutics Development 16
Bone Marrow Transplant Rejection 16
Graft Versus Host Disease (GVHD) 27
Liver Transplant Rejection 38

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overview of Transplantation Drug Development Pipeline Industry : Size, Share, Trends and Analysis 2017 here

News-ID: 889580 • Views:

More Releases for Transplant

Global Tacrolimus Injection Market Size, Share & Trends Analysis Report, By Appl …
The global tacrolimus injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus, also known as Prograf, is an immunosuppressive drug primarily used with other medications to prevent rejection of a heart, kidney, or liver transplant in adult and pediatric patients. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection so as to prevent
Organ Transplant Market | Organogenesis Incorporated, Terumo Co., OrganOX, Trans …
Organ Transplant Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Organ Transplant Market. Organ Transplant Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the
hair transplant services
Hair transplant is a surgical procedures that moves hair follicles from one part of the body to another part of the body. Hair transplantation is chiefly used to treat the baldness in male and female. The global hair transplant services market is witnessing a rise in its demand. The market is segmented into three major transplant procedures like scalp reduction, follicular unit strip surgery and follicular unit extraction. Increasing importance regarding
Organ Transplant Immunosuppressant Drugs Market By Drug Class, By Transplant, By …
This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow. Organ dysfunction caused due to severe injuries, cancer, organ failure and/or genetic disorders necessitate the requirement for organ transplant procedures. Thus, rise in the number of